Stay informed with the latest litigation news. Explore now

IP Verse

Shionogi competitive analysis

Latest publications and patents of Shionogi New

Explore the latest publications and patents granted to Shionogi, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Shionogi

EP3045206
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivityPatent Maintained As Amended
EP3616720
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentGranted And Under Opposition
EP2772480
Dec 9, 2020Hiv Replication InhibitorPatent Maintained As Amended
EP3431105
Jan 1, 2020Medicinal Composition For Treating CancerGranted And Under Opposition
EP3284520
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivityOpposition Rejected
EP2266958
Mar 15, 2017Antiviral AgentRevoked

Latest patents of Shionogi opposed by its competitors

Explore Shionogi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3045206
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP3616720
Feb 17, 2021Pharmaceutical Composition For Cancer Treatment10
EP2772480
Dec 9, 2020Hiv Replication Inhibitor1
EP3431105
Jan 1, 2020Medicinal Composition For Treating Cancer5
EP3284520
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP2266958
Mar 15, 2017Antiviral Agent1

Latest PTAB cases involving Shionogi New

Discover the latest PTAB cases involving Shionogi, highlighting their recent legal challenges and patent disputes.

Top competitors of Shionogi

Top competitors of Shionogi based on patent oppositions.